2023 - Research.com Genetics in United Kingdom Leader Award
2008 - Fellow of the American Association for the Advancement of Science (AAAS)
His primary scientific interests are in Genetics, Gene, Genome, Mutation and Cancer research. His Genome study combines topics from a wide range of disciplines, such as International Knockout Mouse Consortium, Computational biology and Laboratory mouse. His studies deal with areas such as Cancer and Molecular biology as well as Mutation.
His Cancer study incorporates themes from Insertional mutagenesis, Germline and DNA methylation. His work on Melanoma as part of general Cancer research study is frequently linked to Competing endogenous RNA, bridging the gap between disciplines. David J. Adams usually deals with Endocrinology and limits it to topics linked to Ion channel and Cell biology.
His scientific interests lie mostly in Genetics, Pharmacology, Gene, Cancer research and Internal medicine. His is involved in several facets of Genetics study, as is seen by his studies on Genome, Mutation, Cancer, Insertional mutagenesis and Phenotype. The various areas that he examines in his Pharmacology study include Conotoxin, Voltage-dependent calcium channel, Nicotinic agonist, GABAB receptor and Acetylcholine receptor.
His work investigates the relationship between Conotoxin and topics such as Nicotinic acetylcholine receptor that intersect with problems in Stereochemistry. His research in Cancer research is mostly concerned with Melanoma. In his study, Biophysics is strongly linked to Endocrinology, which falls under the umbrella field of Internal medicine.
Cancer research, Gene, Melanoma, Computational biology and Pharmacology are his primary areas of study. His Cancer research research incorporates themes from Carcinogenesis, Mutation, Immune system, Antigen and Germline. His Gene research includes themes of Function and Cell biology.
His Computational biology research is multidisciplinary, relying on both Genome, Genomics and Mutation rate. His biological study spans a wide range of topics, including Acetylcholine receptor, α conotoxin, Nicotinic agonist and Nicotinic acetylcholine receptor. His study with Mutant involves better knowledge in Genetics.
His primary areas of investigation include Cancer research, Computational biology, Gene, Genome and Melanoma. The concepts of his Cancer research study are interwoven with issues in Wnt signaling pathway, Mutation, Carcinogenesis, Germline and Metastasis. David J. Adams combines subjects such as Cancer, Genome editing, CRISPR, Point mutation and Genomics with his study of Computational biology.
His Gene research integrates issues from Interleukin 4 and Cell biology. His research integrates issues of In silico, Model organism, DNA sequencing and Human genetics in his study of Genome. His Germline mutation research is classified as research in Genetics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance
William A. Zoghbi;David Adams;Robert O. Bonow;Maurice Enriquez-Sarano.
Journal of The American Society of Echocardiography (2017)
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Andrew V. Biankin;Andrew V. Biankin;Andrew V. Biankin;Nicola Waddell;Karin S. Kassahn;Marie Claude Gingras.
Exome sequencing identifies frequent mutation of the SWI/SNF Complex Gene PBRM1 in renal carcinoma
Ignacio Varela;Patrick Tarpey;Keiran Raine;Dachuan Huang.
Mouse genomic variation and its effect on phenotypes and gene regulation
T M Keane;L Goodstadt;P Danecek;M A White.
The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus
Abraham L. Brass;Abraham L. Brass;Abraham L. Brass;I-Chueh Huang;Yair Benita;Sinu P. John.
Pan-cancer analysis of whole genomes
Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
Peter Bouwman;Amal Mahmoud Aly;Jose M. Escandell;Mark Pieterse.
Nature Structural & Molecular Biology (2010)
High-throughput discovery of novel developmental phenotypes
Mary E. Dickinson;Ann M. Flenniken;Xiao Ji;Lydia Teboul.
IFITM3 restricts the morbidity and mortality associated with influenza
Aaron R. Everitt;Simon Clare;Thomas Charles Pertel;Sinu P. John.
In Vivo Identification of Tumor- Suppressive PTEN ceRNAs in an Oncogenic BRAF-Induced Mouse Model of Melanoma
Florian A. Karreth;Yvonne Tay;Daniele Perna;Ugo Ala;Ugo Ala.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: